Biofrontera (BFRI) Revenue Growth (3y) (2023 - 2025)
Biofrontera (BFRI) Revenue Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 2.94% |
| 10 | Biofrontera | 10.88 Mn | 4.47 Mn | 14.09 Mn | 19.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.01% |
| Sep 30, 2025 | 17.37% |
| Jun 30, 2025 | 26.54% |
| Mar 31, 2025 | -4.15% |
| Dec 31, 2024 | 41.69% |
| Sep 30, 2024 | 27.64% |
| Jun 30, 2024 | 10.22% |
| Mar 31, 2024 | 18.59% |
| Dec 31, 2023 | 7.32% |
| Sep 30, 2023 | 39.86% |